Citadel Advisors’s Merus Labs International Inc. MSLI Stock Holding History

Citadel Advisors’s Portfolio MSLI Stock Details MSLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-25,195	Closed	-$31K	–	8508
2017 Q2	$31K	Buy	25,195 +3,369	+15%	+$3.5K	﹤0.01%	7199
2017 Q1	$20K	Sell	21,826 -14,729	-40%	-$12.7K	﹤0.01%	7251
2016 Q4	$32K	Buy	36,555 +17,637	+93%	+$16.2K	﹤0.01%	6980
2016 Q3	$19K	Sell	18,918 -2,582	-12%	-$2.91K	﹤0.01%	7078
2016 Q2	$27K	Buy	+21,500	New	+$30K	﹤0.01%	6542
2016 Q1	–	Sell	-17,961	Closed	-$29K	–	8813
2015 Q4	$29K	Buy	+17,961	New	+$24.4K	﹤0.01%	7689
2015 Q3	–	Sell	-15,669	Closed	-$37K	–	9477
2015 Q2	$37K	Buy	+15,669	New	+$38K	﹤0.01%	7860

Citadel Advisors's MSLI Position: Q3 2017 in Review

Citadel Advisors sold out of Merus Labs International Inc. (MSLI) in Q3 2017, closing a stake of 25,195 shares — an estimated $31K sold.

Citadel Advisors first reported a position in MSLI in Q2 2015 and held it in 7 quarters. The position peaked at $37K in Q2 2015. 0 funds tracked by Wall St. Rank hold MSLI as of Q3 2017.

Citadel Advisors reported no remaining Merus Labs International Inc. position as of Q3 2017 after selling out during the quarter.
Citadel Advisors sold 25,195 Merus Labs International Inc. shares in Q3 2017, an estimated $31K.
Citadel Advisors first reported a position in Merus Labs International Inc. in Q2 2015 and held it in 7 quarters.
Citadel Advisors's Merus Labs International Inc. position peaked at $37K in Q2 2015.
0 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q3 2017.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.